Peripheral blood inflammatory biomarkers neutrophil/ lymphocyte ratio, platelet/lymphocyte ratio and systemic immune-inflammation index/albumin ratio predict prognosis and efficacy in non-small cell lung cancer patients receiving immunotherapy and opioids

Peripheral blood inflammatory biomarkers neutrophil/ lymphocyte ratio, platelet/lymphocyte ratio and systemic immune-inflammation index/albumin ratio predict prognosis and efficacy in non-small cell lung cancer patients receiving immunotherapy and opioids

Abstract Objective The study aimed to assess the value of pretreatment peripheral blood neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR) and systemic immune-inflammation index/albumin ratio (SII/ALB) for predicting immunotherapy prognosis and efficacy in Non-small cell lung carcino...

Full description

Saved in:
Bibliographic Details
Main Authors: Yan Lei, Chengsong Cao, Rui Tang, Yong Liu
Format: Article
Language:English
Published: BMC 2025-04-01
Series:BMC Cancer
Subjects:
Peripheral blood inflammatory marker
Immune checkpoint inhibitors
Opioids
Cancer pain
Non-small cell lung cancer
Prognostic value
Online Access:https://doi.org/10.1186/s12885-025-14060-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-14060-9

Similar Items